Fig. 5

Deletion of TAK1 from myeloid cells resulted in reduced infarct and improved functional outcomes at day 7 post stroke. a TAK1^ΔM mice had lower neurological deficit scores. b TAK1^ΔM mice had less turning bias in the corner test. c No differences were seen in locomotor activity. d Decreased infarcts were seen at day 7 post stroke. Data is presented as mean ± SEM, n = 8; *p < 0.05, **p < 0.01 (two-sample t test or Wilcoxon rank-sum test)